Spotlight on ...

Spotlight on ...


Glut1 – A target for Psoriasis treatment

Glut1 - A Target for Psoriasis Treatment

On-going Mechanical Damage from Mastication Drives Homeostatic Th17 Cell Responses at the Oral Barrier

we currently offer in vivo models of rheumatoid arthritis, psoriasis and inflammatory bowel disease.

New insights into epithelial barrier dysfunction in the intestine: relevance for IBD

Alterations in the complex inter-relationship between intestinal epithelial cells, the mucosal immune system responses and the gut microbiota are responsible for the development of inflammatory bowel disease in humans.